From the Food and Drug Administration.
Nightingale
S L
SL
Associate Commissioner for Health Affairs.
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000818:Animals; D000855:Anorexia / Q000150:complications / Q000188:drug therapy*; D013759:Dronabinol / Q000627:therapeutic use*; D006801:Humans; D008691:Methadone / Q000627:therapeutic use*; D008974:Mollusca / Q000382:microbiology*; D009293:Opioid-Related Disorders / Q000534:rehabilitation*; D012758:Shellfish / Q000382:microbiology*; D014481:United States; D014486:United States Food and Drug Administration; D014735:Vibrio Infections / Q000209:etiology*; D015431:Weight Loss
D013759:Dronabinol; D008691:Methadone